期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade 被引量:19
1
作者 Takatsugu Oida Kenji Mimatsu +4 位作者 Hiso Kano Atsushi Kawasaki Youichi Kuboi Nobutada Fukino Sadao Amano 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第6期740-744,共5页
AIM:To evaluate the role and outcome of pericardiocentesis with intrapericardial cisplatin instillation for malignant pericardial effusion resulting from esophageal cancer. METHODS:We retrospectively studied 7 patient... AIM:To evaluate the role and outcome of pericardiocentesis with intrapericardial cisplatin instillation for malignant pericardial effusion resulting from esophageal cancer. METHODS:We retrospectively studied 7 patients who underwent pericardiocentesis with intrapericardial cisplatin instillation for malignant pericardial effusion resulting from esophageal cancer.After pericardiocentesis,we performed catheterization of the pericardial space under ultrasonogram guidance.Malignant etiology of the pericardial fluid was confirmed by cytological examination.Subsequently,cisplatin(10 mg in 20 mL normal saline) was instilled into the pericardial space. RESULTS:The mean total volume of the aspirated effusion fluid was 782±264 mL(range,400-1200 mL) . The drainage catheter was successfully removed in all patients,and the mean duration of pericardial drainagewas 7.7±2.7 d(range,5-13 d) .No fluid reaccumulation was observed.Mean survival time was 120±71 d(range,68-268 d) . CONCLUSION:Pericardiocentesis along with catheter drainage appears to be a safe and effective for pericardial malignant effusion and tamponade,and cisplatin instillation prevents recurrence. 展开更多
关键词 malignant pericardial effusion Cardiac tamponade Esophageal cancer PERICARDIOCENTESIS CISPLATIN
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部